COM:ELEVATIONONCOLOGY
Elevation Oncology, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
elevationoncology.comcrunchbase
elevation-oncologylinkedin
elevation-oncologyfounding date
Jan 01, 2019ipo date
Jun 25, 2021
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-...Show More